Is the prevalence of ER-negative breast cancer in the US higher among Africa-born than US-born black women?

Breast Cancer Research and Treatment

Volumn 135, Issue 3, 2012, Pages 867-873

  Jemal, Ahmedin ^a   Fedewa, Stacey A ^a  

^a AMERICAN CANCER SOCIETY   (United States)

Author keywords

African Americans; Breast cancer; Epidemiology; Estrogen receptor status

Indexed keywords

AFRICA; ARTICLE; BREAST CANCER; CANCER REGISTRY; CAUCASIAN; CONTROLLED STUDY; ETHIOPIA; FEMALE; HUMAN; JAMAICA; MAJOR CLINICAL STUDY; NEGRO; NIGERIA; PREVALENCE; PRIORITY JOURNAL; RACE DIFFERENCE; UNITED STATES;

AFRICA, EASTERN; AFRICA, WESTERN; AFRICAN AMERICANS; AFRICAN CONTINENTAL ANCESTRY GROUP; AGED; BREAST NEOPLASMS; ETHIOPIA; FEMALE; HUMANS; JAMAICA; MIDDLE AGED; NIGERIA; RECEPTORS, ESTROGEN; SEER PROGRAM;

EID: 84866557085     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/s10549-012-2214-2     Document Type: Article

References (31)

1. Miller BA, Hankey BF, Thomas TL (2002) Impact of sociodemographic factors, hormone receptor status, and tumor grade on ethnic differences in tumor stage and size for breast cancer in US women. Am J Epidemiol 155:534-545 (Pubitemid 34208045)
2. DeSantis C, Jemal A, Ward E (2010) Disparities in breast cancer prognostic factors by race, insurance status, and education. Cancer Causes Control 21:1445-1450
3. Joslyn SA (2002) Hormone receptors in breast cancer: racial differences in distribution and survival. Breast Cancer Res Treat 73:45-59 (Pubitemid 34548165)
4. Chlebowski RT, Chen Z, Anderson GL, Rohan T, Aragaki A, Lane D, Dolan NC, Paskett ED, McTiernan A, Hubbell FA, Adams-Campbell LL, Prentice R (2005) Ethnicity and breast cancer: factors influencing differences in incidence and outcome. J Natl Cancer Inst 97:439-448
5. Anderson WF, Jatoi I, Devesa SS (2005) Distinct breast cancer incidence and prognostic patterns in the NCI's SEER program: suggesting a possible link between etiology and outcome. Breast Cancer Res Treat 90:127-137 (Pubitemid 40568896)
6. Singh GK, Hiatt RA (2006) Trends and disparities in socioeconomic and behavioural characteristics, life expectancy, and cause-specific mortality of native-born and foreign-born populations in the United States, 1979-2003. Int J Epidemiol 35:903-919 (Pubitemid 44540740)
7. Carlson RW, Anderson BO, Chopra R, Eniu AE, Jakesz R, Love RR, Masetti R, Schwartsmann G (2003) Treatment of breast cancer in countries with limited resources. Breast J 9(Suppl 2):S67-S74 (Pubitemid 36627149)
8. Bird PA, Hill AG, Houssami N (2008) Poor hormone receptor expression in East African breast cancer: evidence of a biologically different disease? Ann Surg Oncol 15:1983-1988
9. Huo D, Ikpatt F, Khramtsov A, Dangou JM, Nanda R, Dignam J, Zhang B, Grushko T, Zhang C, Oluwasola O, Malaka D, Malami S, Odetunde A, Adeoye AO, Iyare F, Falusi A, Perou CM, Olopade OI (2009) Population differences in breast cancer: survey in indigenous African women reveals over-representation of triplenegative breast cancer. J Clin Oncol 27:4515-4521
10. Ikpatt OF, Kuopio T, Ndoma-Egba R, Collan Y (2002) Breast cancer in Nigeria and Finland: epidemiological, clinical and histological comparison. Anticancer Res 22:3005-3012 (Pubitemid 36069350)
11. Stark A, Kleer CG, Martin I, Awuah B, Nsiah-Asare A, Takyi V, Braman M, Quayson SE, Zarbo R, Wicha M, Newman L (2010) African ancestry and higher prevalence of triple-negative breast cancer: findings from an international study. Cancer 116:4926-4932
12. S.E.E.R.*Stat Database: Incidence-SEER 17 Regs Research Data, Nov 2010 Sub (1973-2008) \Katrina/Rita Population Adjustment[-Linked To County Attributes-Total US, 1969-2009 (2010). In: Surveillance Epidemiology and End Result (SEER) Program. www.seer.cancer.gov. National Cancer Institute, DCCPS, Surveillance Research Program, Cancer Statistics Branch, Bethesda
13. Ma H, Wang Y, Sullivan-Halley J, Weiss L, Burkman RT, Simon MS, Malone KE, Strom BL, Ursin G, Marchbanks PA, McDonald JA, Spirtas R, Press MF, Bernstein L (2009) Breast cancer receptor status: do results from a centralized pathology laboratory agree with SEER registry reports? Cancer Epidemiol Biomarkers Prev 18:2214-2220
14. Allred DC (1993) Should immunohistochemical examination replace biochemical hormone receptor assays in breast cancer? Am J Clin Pathol 99:1-3 (Pubitemid 23030660)
15. Collaborative Staging Manual and Coding Instructions (2007) In: Cancer Collaborative Staging Task Force of the American Joint Committee on Cancer (ed). American Joint Commission on Cancer and US Department of Health and Human Services, Bethesda
16. SEER Place of Birth Coding Manual National Cancer Institute, Surveillance Epidemiology and End Results, http://seer.cancer. gov/manuals/2011/SPCSM-2011- AppendixB.pdf
17. Gomez SL, Glaser SL, Kelsey JL, Lee MM (2004) Bias in completeness of birthplace data for Asian groups in a populationbased cancer registry (United States). Cancer Causes Control 15:243-253 (Pubitemid 38988033)
18. Feliciano C (2005) Educational selectivity in US immigration: how do immigrants compare to those left behind? Demography 42:131-152 (Pubitemid 40473369)
19. Deddens JA, Petersen MR (2008) Approaches for estimating prevalence ratios. Occup Environ Med 65(481):486-501
20. Krieger N, Chen JT, Waterman PD (2011) Temporal trends in the black/white breast cancer case ratio for estrogen receptor status: disparities are historically contingent, not innate. Cancer Causes Control 22:511-514
21. SAS Institute Inc. (2008) SAS/STAT- 9.2 User's Guide. SAS Institute Inc, Cary
22. Althuis MD, Fergenbaum JH, Garcia-Closas M, Brinton LA, Madigan MP, Sherman ME (2004) Etiology of hormone receptordefined breast cancer: a systematic review of the literature. Cancer Epidemiol Biomarkers Prev 13:1558-1568 (Pubitemid 39331875)
23. Colditz GA, Rosner BA, Chen WY, Holmes MD, Hankinson SE (2004) Risk factors for breast cancer according to estrogen and progesterone receptor status. J Natl Cancer Inst 96:218-228 (Pubitemid 38263181)
24. Millikan RC, Newman B, Tse CK, Moorman PG, Conway K, Dressler LG, Smith LV, Labbok MH, Geradts J, Bensen JT, Jackson S, Nyante S, Livasy C, Carey L, Earp HS, Perou CM (2008) Epidemiology of basal-like breast cancer. Breast Cancer Res Treat 109:123-139 (Pubitemid 351538762)
25. Vrieling A, Buck K, Kaaks R, Chang-Claude J (2010) Adult weight gain in relation to breast cancer risk by estrogen and progesterone receptor status: a meta-analysis. Breast Cancer Res Treat 123:641-649
26. Yang XR, Chang-Claude J, Goode EL, Couch FJ, Nevanlinna H, Milne RL, Gaudet M, Schmidt MK, Broeks A, Cox A, Fasching PA, Hein R, Spurdle AB, Blows F, Driver K, Flesch-Janys D, Heinz J, Sinn P, Vrieling A, Heikkinen T, Aittomaki K, Heikkila P, Blomqvist C, Lissowska J, Peplonska B, Chanock S, Figueroa J, Brinton L, Hall P, Czene K, Humphreys K, Darabi H, Liu J, Van 't Veer LJ, van Leeuwen FE, Andrulis IL, Glendon G, Knight JA, Mulligan AM, O'Malley FP, Weerasooriya N, John EM, Beckmann MW, Hartmann A, Weihbrecht SB, Wachter DL, Jud SM, Loehberg CR, Baglietto L, English DR, Giles GG, McLean CA, Severi G, Lambrechts D, Vandorpe T, Weltens C, Paridaens R, Smeets A, Neven P, Wildiers H, Wang X, Olson JE, Cafourek V, Fredericksen Z, Kosel M, Vachon C, Cramp HE, Connley D, Cross SS, Balasubramanian SP, Reed MW, Dork T, Bremer M, Meyer A, Karstens JH, Ay A, Park-Simon TW, Hillemanns P, Arias Perez JI, Menendez Rodriguez P, Zamora P, Benitez J, Ko YD, Fischer HP, Hamann U, Pesch B, Bruning T, Justenhoven C, Brauch H, Eccles DM, Tapper WJ, Gerty SM, Sawyer EJ, Tomlinson IP, Jones A, Kerin M, Miller N, McInerney N, Anton-Culver H, Ziogas A, Shen CY, Hsiung CN, Wu PE, Yang SL, Yu JC, Chen ST, Hsu GC, Haiman CA, Henderson BE, Le Marchand L, Kolonel LN, Lindblom A, Margolin S, Jakubowska A, Lubinski J, Huzarski T, Byrski T, Gorski B, Gronwald J, Hooning MJ, Hollestelle A, van den Ouweland AM, Jager A, Kriege M, Tilanus-Linthorst MM, Collee M, Wang-Gohrke S, Pylkas K, Jukkola-Vuorinen A, Mononen K, Grip M, Hirvikoski P, Winqvist R, Mannermaa A, Kosma VM, Kauppinen J, Kataja V, Auvinen P, Soini Y, Sironen R, Bojesen SE, Orsted DD, Kaur-Knudsen D, Flyger H, Nordestgaard BG, Holland H, Chenevix-Trench G, Manoukian S, Barile M, Radice P, Hankinson SE, Hunter DJ, Tamimi R, Sangrajrang S, Brennan P, McKay J, Odefrey F, Gaborieau V, Devilee P, Huijts PE, Tollenaar RA, Seynaeve C, Dite GS, Apicella C, Hopper JL, Hammet F, Tsimiklis H, Smith LD, Southey MC, Humphreys MK, Easton D, Pharoah P, Sherman ME, Garcia-Closas M (2011) Associations of breast cancer risk factors with tumor subtypes: a pooled analysis from the Breast Cancer Association Consortium studies. J Natl Cancer Inst 103:250-263
27. Fregene A, Newman LA (2005) Breast cancer in sub-Saharan Africa: how does it relate to breast cancer in African-American women? Cancer 103:1540-1550 (Pubitemid 40490014)
28. Salas A, Richards M, Lareu MV, Scozzari R, Coppa A, Torroni A, Macaulay V, Carracedo A (2004) The African diaspora: mitochondrial DNA and the Atlantic slave trade. Am J Hum Genet 74:454-465 (Pubitemid 38325916)
29. Krieger N, Chen JT, Ware JH, Kaddour A (2008) Race/ethnicity and breast cancer estrogen receptor status: impact of class, missing data, and modeling assumptions. Cancer Causes Control 19:1305-1318
30. Collins LC, Marotti JD, Baer HJ, Tamimi RM (2008) Comparison of estrogen receptor results from pathology reports with results from central laboratory testing. J Natl Cancer Inst 100:218-221 (Pubitemid 351480544)
31. Parker RL, Huntsman DG, Lesack DW, Cupples JB, Grant DR, Akbari M, Gilks CB (2002) Assessment of interlaboratory variation in the immunohistochemical determination of estrogen receptor status using a breast cancer tissue microarray. Am J Clin Pathol 117:723-728 (Pubitemid 34457006)